ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Free cash flow 2017–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$48.9MFY2025 · since FY2017: -$37.3M → -$48.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$48.9M | +50.5% |
| FY2024 | -$98.9M | +40.8% |
| FY2023 | -$167.0M | +16.6% |
| FY2022 | -$200.3M | +21.3% |
| FY2021 | -$254.5M | -51.0% |
| FY2020 | -$168.5M | -186.8% |
| FY2019 | $194.2M | +603.7% |
| FY2018 | -$38.6M | -3.4% |
| FY2017 | -$37.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice